Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 4 (cut20), partial

Shipped with Ice Packs
In Stock

Description

APC/C Subunit Composition and Role of APC4

The APC/C is a 13–15 subunit E3 ubiquitin ligase essential for cell cycle progression. In S. pombe, APC4 (Lid1) is a core scaffolding subunit (Table 1) that stabilizes the complex architecture and mediates interactions with co-activators like Cdc20 .

  • Metaphase-to-Anaphase Transition: APC4/Lid1 interacts with the co-activator Cdc20 to promote ubiquitination of securin and cyclin B, enabling separase activation and sister chromatid separation .

  • Checkpoint Regulation: Lid1 is required for the spindle assembly checkpoint (SAC) to inhibit APC/C activity until all chromosomes achieve proper microtubule attachment .

  • Meiotic Coordination: Phosphorylation of APC4 during meiosis regulates cohesin cleavage (e.g., Rec8) to maintain centromeric cohesion until anaphase II .

Recombinant Production and Applications

While direct studies on recombinant S. pombe APC4/Cut20 are sparse, S. pombe is a well-established system for recombinant protein expression due to its mammalian-like post-translational modifications . Key findings include:

  • Expression Systems: S. pombe strains engineered for synchronous meiosis (e.g., pat1-114 or pat1-as2) enable large-scale proteomic studies of APC/C subunits .

  • Structural Studies: Cryo-EM and mass spectrometry of recombinant APC/C subunits (e.g., Apc2-Apc11 catalytic core) reveal conserved mechanisms of ubiquitin ligation .

Research Gaps and Challenges

  • Nomenclature Clarity: The designation "Cut20" is not widely documented in S. pombe APC/C studies, suggesting potential discrepancies in naming conventions.

  • Partial Constructs: Truncated APC4 variants (e.g., lacking TPR domains) may impair APC/C assembly, necessitating further biochemical validation .

Future Directions

  • Phosphoproteomics: Mapping phosphorylation sites on recombinant APC4 during meiosis could elucidate regulatory mechanisms .

  • Drug Discovery: Targeting APC4-coactivator interfaces (e.g., Cdc20 binding) may yield therapeutics for mitotic disorders .

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have specific requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance, as extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you have a specific tag preference, please inform us, and we will prioritize its development.
Synonyms
cut20; apc4; lid1; SPAC19G12.01c; SPAPJ698.04cAnaphase-promoting complex subunit 4; 20S cyclosome/APC complex protein apc4; Cell untimely torn protein 20
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
Target Names
cut20
Uniprot No.

Target Background

Function
Part of the anaphase-promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin-protein ligase complex. The APC/C controls progression through mitosis and the G1 phase. It provides substrate specificity and, with E2 enzymes, catalyzes protein ubiquitination, leading to degradation by the 26S proteasome. It promotes the metaphase-to-anaphase transition by ubiquitinating specific mitotic substrates.
Database Links

Q&A

What is the structural organization of Cut20/Apc4 within the APC/C complex?

Cut20/Apc4 is one of the thirteen subunits of the Schizosaccharomyces pombe APC/C complex. Cryo-electron microscopy has revealed that the APC/C forms a triangular-shaped structure approximately 19 × 17 × 15 nm in size, with a deep internal cavity and a distinctive horn-like protrusion extending from the cavity lip . Within this structure, Cut20 interacts closely with Cut4 during the assembly process of the cyclosome . The positioning of Cut20 has been determined through antibody labeling techniques, contributing to our comprehensive model of APC/C organization . For experimental characterization of Cut20, researchers typically use immunoprecipitation with tagged versions of the protein followed by mass spectrometry to identify interaction partners.

How does Cut20 differ functionally from other APC/C subunits in S. pombe?

While all APC/C subunits contribute to the complex's ubiquitin ligase activity, Cut20 exhibits some unique properties. Unlike some other APC/C components, Cut20 mutants (cut20-100) show specific hypersensitivity to canavanine and CdCl₂, and their defects can be suppressed by PKA-inactivating regulators . Additionally, Cut20 is uniquely suppressed by the stw1+ gene, which does not suppress mutations in other subunits like Cut4 . These distinctive properties suggest that Cut20 may have evolved specialized functions within the APC/C, potentially in substrate recognition or in mediating particular regulatory interactions. Experimental approaches to distinguish Cut20's specific functions typically involve comparative genetic screens using different APC/C subunit mutants and analyzing differential phenotypic outcomes.

What expression systems are most effective for producing recombinant Cut20 protein?

For recombinant production of functional Cut20 protein, bacterial expression systems often yield insoluble protein due to improper folding. More successful approaches include:

  • S. pombe expression system: Expressing tagged versions (6×His, GST, or FLAG) of Cut20 in its native organism preserves proper folding and post-translational modifications.

  • Insect cell expression: Baculovirus-infected Sf9 or High Five cells provide eukaryotic processing machinery suitable for complex proteins like Cut20.

  • Cell-free systems: These can be optimized for difficult-to-express proteins and allow immediate purification.

The experimental workflow typically involves:

  • Cloning the cut20+ gene into an appropriate expression vector

  • Transforming/transfecting the host system

  • Inducing expression under optimized conditions

  • Purification via affinity chromatography

  • Verification of proper folding through circular dichroism or limited proteolysis

Protein yield and solubility should be assessed through standard Bradford assays and SDS-PAGE analysis to determine the most efficient expression system for your specific experimental requirements.

What are the most reliable approaches for studying Cut20's interactions with other APC/C components?

To study Cut20's interactions with other APC/C components, researchers employ several complementary techniques:

TechniqueApplicationAdvantagesLimitations
Co-immunoprecipitationDirect protein interactionsPreserves native complexesMay capture indirect interactions
Yeast two-hybridBinary protein interactionsHigh-throughput screeningHigh false positive rate
Proximity labeling (BioID)Protein neighborhood mappingDetects transient interactionsRequires genetic modification
Cryo-EMStructural organizationVisualizes entire complexLower resolution for individual subunits
Crosslinking mass spectrometryInteraction interfacesIdentifies specific contact pointsComplex data analysis

The most definitive results come from combining these approaches. For example, researchers have successfully used immunoprecipitation with Cut20-Myc or Cut20-FLAG tagged proteins to isolate intact APC/C complexes . The resulting complexes can then be analyzed by mass spectrometry to identify all interacting partners. These approaches have revealed that Cut20 interacts closely with Cut4 during the assembly process of the cyclosome .

How can temperature-sensitive cut20 mutants be effectively used to study APC/C function?

Temperature-sensitive (ts) cut20 mutants are valuable tools for studying APC/C function in S. pombe. The effective experimental approach includes:

  • Mutant isolation: Screen for temperature-sensitive colonies after mutagenesis. The cut20-100 mutant was identified among 555 temperature-sensitive mutants showing the characteristic "cut" (cell untimely torn) phenotype .

  • Phenotypic characterization: At restrictive temperature (typically 36°C), document cell cycle arrest points, cell morphology, and nuclear division defects using DAPI staining and microscopy.

  • Synchronization experiments: Use nitrogen starvation or elutriation to synchronize cells, then shift to restrictive temperature at specific cell cycle stages to determine when Cut20 function is required.

  • Suppressor screening: Identify genes that, when overexpressed, can rescue the ts phenotype. This approach identified that while PKA-inactivating regulators suppress both cut20 and cut4 mutants, the novel stw1+ gene specifically suppresses only cut20 mutant phenotypes .

  • Biochemical assays: Compare APC/C activity at permissive (25°C) and restrictive temperatures using in vitro ubiquitination assays with known substrates like mitotic cyclins or Cut2/securin.

The unique advantage of ts mutants is the ability to conditionally inactivate Cut20 function, allowing researchers to distinguish between direct effects of Cut20 loss and secondary consequences that would be masked in null mutants (which are typically lethal for essential genes like cut20).

What experimental design best reveals Cut20's role in the spindle assembly checkpoint?

To elucidate Cut20's role in the spindle assembly checkpoint (SAC), a comprehensive experimental design should include:

  • Microtubule depolymerization experiments: Treat wild-type and cut20 mutant cells with microtubule-depolymerizing drugs (thiabendazole or carbendazim) and monitor:

    • Mitotic arrest duration

    • Mad2/Mph1 localization to kinetochores

    • Premature degradation of Cdc13 (cyclin B) and Cut2 (securin)

  • Genetic interaction analysis: Construct double mutants between cut20 and known SAC components (mad1Δ, mad2Δ, mph1Δ, bub1Δ) to assess epistatic relationships.

  • Live-cell imaging: Using fluorescently tagged chromosomes and spindle markers in cut20 mutant backgrounds to visualize chromosome segregation dynamics.

  • Immunoprecipitation studies: Under SAC-activating conditions, compare the association of Cut20 with:

    • Other APC/C components

    • The mitotic checkpoint complex (MCC)

    • Slp1/Cdc20 (the APC/C activator in S. pombe)

  • In vitro reconstitution: Assemble APC/C complexes with wild-type or mutant Cut20 and assess their susceptibility to inhibition by recombinant MCC components.

This multi-faceted approach can distinguish between direct involvement of Cut20 in SAC signaling versus indirect effects caused by general APC/C dysfunction. Since Cdc20 serves as the target of the spindle assembly checkpoint that prevents anaphase onset until chromosomes are correctly attached to the mitotic spindle , understanding Cut20's interaction with this process is crucial for comprehending mitotic regulation.

How do post-translational modifications of Cut20 regulate APC/C activity during the cell cycle?

Post-translational modifications (PTMs) of Cut20 likely play crucial roles in regulating APC/C activity. While specific modifications of S. pombe Cut20 are still being characterized, research approaches should include:

  • Phosphorylation mapping: Using phospho-specific antibodies or mass spectrometry to identify Cut20 phosphorylation sites that change during cell cycle progression. Key kinases to investigate include Cdc2/CDK1, Polo kinase (Plo1), and PKA (given the genetic interaction between Cut20 and PKA-inactivating regulators ).

  • Phosphomimetic and phospho-dead mutations: Creating Cut20 variants where potential phosphorylation sites are mutated to either mimic permanent phosphorylation (S/T→D/E) or prevent phosphorylation (S/T→A). These can be tested for their ability to:

    • Incorporate into the APC/C complex

    • Support APC/C-mediated ubiquitination

    • Rescue cut20 mutant phenotypes

  • Ubiquitination analysis: Determining if Cut20 itself undergoes cell cycle-dependent ubiquitination, potentially affecting APC/C assembly or activity. This is particularly relevant given observations that Cut23, another APC/C component, "may be ubiquitinated and degraded in a cell cycle dependent fashion" .

  • In vitro reconstitution: Reconstituting APC/C activity using recombinant components with defined modification states to directly assess how specific PTMs affect complex assembly and activity.

Results from these approaches would provide mechanistic insights into how Cut20 contributes to the temporal regulation of APC/C activity during mitotic progression.

What structural features of Cut20 are essential for proper APC/C assembly versus catalytic function?

Distinguishing between Cut20's structural and catalytic contributions requires detailed structure-function analysis:

  • Domain mapping: Using truncation and internal deletion mutants to identify regions essential for:

    • APC/C incorporation (structural role)

    • E3 ligase activity (catalytic role)

    • Substrate selectivity

  • Point mutation analysis: Based on evolutionary conservation and structural predictions, create point mutations in suspected functional domains and assess their impact on:

    • Complex formation (assessed by co-immunoprecipitation)

    • Ubiquitination activity (in vitro assays)

    • Cell cycle progression (in vivo complementation)

  • Cryo-EM structural analysis: Generate 3D reconstructions of APC/C with wild-type versus mutant Cut20 to visualize conformational changes. The existing triangular-shaped structure with dimensions of ~19 × 17 × 15 nm provides a baseline for comparison .

  • Crosslinking studies: Use chemical crosslinking followed by mass spectrometry to map interaction interfaces between Cut20 and other APC/C subunits in both active and inactive complexes.

This approach has revealed that Cut20 interacts closely with Cut4 during the assembly process of the cyclosome , suggesting a critical structural role, but may also contribute to catalytic functions through proper positioning of other subunits.

How does the stoichiometry of Cut20 within the APC/C complex affect its functional properties?

Understanding the impact of Cut20 stoichiometry on APC/C function requires sophisticated quantitative approaches:

  • Quantitative proteomics: Use SILAC (Stable Isotope Labeling with Amino acids in Cell culture) or TMT (Tandem Mass Tag) approaches to precisely determine the stoichiometry of Cut20 relative to other APC/C subunits under different cell cycle stages or stress conditions.

  • Single-molecule approaches: Employ fluorescence correlation spectroscopy or single-molecule pulldowns to determine if sub-populations of APC/C exist with different Cut20 content.

  • Controlled expression systems: Develop strains with titratable Cut20 expression to systematically vary the amount of Cut20 available for APC/C incorporation and measure:

    • Complex assembly efficiency

    • Substrate ubiquitination rates and specificity

    • Cell cycle progression kinetics

  • Competition experiments: In reconstituted systems, introduce wild-type and mutant Cut20 at different ratios to determine how mixed populations affect APC/C function.

Previous research has established subunit stoichiometry for other APC/C components. For instance, Cut9-FLAG and Cut23-FLAG were each 2.1-fold more abundant than Cut4-FLAG, and Nuc2-Myc was 2.2 times more abundant than Cut4-Myc, suggesting that the APC/C contains two copies of each of these three TPR proteins . Similar quantitative approaches should be applied to determine Cut20 stoichiometry and its functional significance.

What are the common pitfalls in purifying functional recombinant Cut20 protein and how can they be overcome?

Purifying functional recombinant Cut20 presents several challenges:

ChallengeSolutionMethodological Details
InsolubilityUse solubility tagsFuse Cut20 with MBP, SUMO, or GST tags; test multiple fusion positions
Improper foldingExpress in eukaryotic systemsInsect cells or S. pombe expression preserves folding machinery
Proteolytic degradationOptimize purification conditionsAdd protease inhibitors; reduce purification time; keep samples cold
Co-purifying contaminantsSequential purificationCombine affinity, ion exchange, and size exclusion chromatography
Low activityInclude co-factorsPurify with binding partners; supplement with ATP/Mg²⁺

Specific protocol recommendations:

  • For bacterial expression, use Arctic Express or SHuffle strains at lower temperatures (16-18°C) with extended induction times.

  • For insect cell expression, incorporate a secretion signal to improve folding and consider using flash-freezing of cell pellets to minimize degradation during cell disruption.

  • For validation of proper folding, compare the activity of your recombinant protein with immunoprecipitated native Cut20 from S. pombe in APC/C reconstitution assays.

What controls are essential when analyzing Cut20 mutant phenotypes to ensure specificity of observations?

Rigorous experimental design for Cut20 mutant analysis requires several critical controls:

  • Genetic complementation: Confirm that wild-type cut20+ expression rescues all observed phenotypes, ruling out secondary mutations.

  • Allele specificity: Compare multiple independent cut20 mutant alleles to identify consistent versus allele-specific phenotypes.

  • Temperature controls: For temperature-sensitive mutations, include both up-shift (restrictive to permissive) and down-shift (permissive to restrictive) experiments to distinguish between reversible and irreversible defects.

  • APC/C subunit comparisons: Analyze phenotypes of mutations in other APC/C subunits (cut4, cut9, nuc2) to distinguish Cut20-specific versus general APC/C defects.

  • Cell cycle synchronization controls: When analyzing cell cycle defects, use multiple synchronization methods to ensure observations aren't artifacts of the synchronization procedure.

  • Quantitative phenotyping: Develop quantitative assays for phenotypes, including:

    • Precise cell cycle timing (time-lapse microscopy)

    • Substrate degradation kinetics (quantitative western blotting)

    • Chromosome segregation fidelity (minichromosome loss assays)

  • Biochemical reconstitution: Confirm that phenotypes observed in vivo can be recapitulated in reconstituted systems with defined components.

How should researchers interpret contradictory findings about Cut20 function between different model systems?

When facing contradictory findings about Cut20 function across different systems:

  • Evaluate evolutionary conservation: Compare sequence and structural homology of Cut20/Apc4 across species to identify conserved versus divergent domains that might explain functional differences.

  • Assess methodological differences: Analyze whether contradictions stem from:

    • Different experimental techniques

    • Varied genetic backgrounds

    • Distinct assay sensitivities

    • Non-equivalent mutant alleles

  • Consider contextual factors: Examine how differences in:

    • Cell cycle regulation

    • APC/C composition

    • Substrate recognition mechanisms

    • Checkpoint controls
      might contribute to apparently contradictory results.

  • Perform comparative studies: Design experiments that directly compare Cut20 function in multiple systems under identical conditions, such as:

    • Heterologous expression of Cut20 from different species in S. pombe

    • In vitro reconstitution with components from different organisms

    • Creation of chimeric Cut20 proteins with domains from different species

  • Utilize phylogenetic approaches: Examine if contradictions reflect authentic evolutionary diversification by mapping functional differences onto phylogenetic trees.

This systematic approach can transform apparent contradictions into insights about evolutionary adaptation of APC/C regulation across different organisms.

What statistical approaches are most appropriate for analyzing complex phenotypic data from Cut20 mutant studies?

Complex phenotypic data from Cut20 mutant studies require sophisticated statistical approaches:

  • Multivariate analysis: When multiple phenotypic parameters are measured (cell size, cell cycle duration, substrate degradation rate, etc.), use:

    • Principal Component Analysis (PCA) to identify major sources of variation

    • Clustering methods to group mutants with similar phenotypic profiles

    • MANOVA (Multivariate Analysis of Variance) to test for significant differences between mutant groups

  • Time series analysis: For cell cycle progression data:

    • Use survival analysis techniques to compare time-to-event data (e.g., time to anaphase)

    • Apply mixed-effects models to account for cell-to-cell variability

    • Employ change-point detection to identify critical transitions

  • Bayesian approaches: Particularly useful for:

    • Integrating prior knowledge about APC/C function

    • Dealing with small sample sizes

    • Modeling complex dependencies between phenotypes

  • Machine learning: For high-dimensional phenotypic data:

    • Random forests can identify the most informative phenotypic features

    • Support vector machines can classify mutants based on phenotypic signatures

    • Deep learning approaches can extract patterns from microscopy images

  • Multiple hypothesis correction: When testing numerous phenotypic parameters:

    • Use Benjamini-Hochberg procedure to control false discovery rate

    • Apply Bonferroni correction for conservative hypothesis testing

    • Consider permutation tests for distribution-free hypothesis testing

Appropriate statistical approaches should be selected based on experimental design, data structure, and specific hypotheses being tested. For example, when analyzing temperature-sensitive cut20 mutants and their interactions with suppressors like stw1+ , factorial designs with appropriate interaction terms should be employed.

How can researchers effectively integrate genetic, biochemical, and structural data to build comprehensive models of Cut20 function?

Integrating multiple data types requires systematic approaches:

  • Data standardization and repository creation: Establish a central repository for Cut20-related data with standardized formats for:

    • Genetic interaction profiles

    • Protein-protein interaction networks

    • Structural coordinates

    • Phenotypic measurements

  • Multi-scale modeling: Develop computational models spanning:

    • Atomic-level structural models of Cut20 within the APC/C

    • Kinetic models of APC/C-mediated ubiquitination

    • Cell cycle progression models incorporating APC/C function

  • Network analysis: Construct integrated networks connecting:

    • Genetic interactions

    • Physical interactions

    • Functional relationships

    • Evolutionary conservation

  • Bayesian integration frameworks: Use Bayesian networks to:

    • Combine evidence from diverse experimental approaches

    • Weight evidence based on reliability and relevance

    • Generate testable predictions for further validation

  • Visualization tools: Develop specialized visualization approaches to represent multi-dimensional data, such as:

    • Interactive 3D structural models with overlaid functional data

    • Temporal evolution maps of APC/C activity and composition

    • Hierarchical representation of genetic interaction networks

This integrated approach has proven successful in building comprehensive models of complex molecular machines. For example, combining cryo-EM structural data on the APC/C's triangular shape (~19 × 17 × 15 nm) with interaction data showing Cut20's close association with Cut4 provides insights into both structure and assembly mechanisms that neither approach alone could achieve.

What emerging technologies will advance our understanding of Cut20's dynamic behavior in live cells?

Several cutting-edge technologies promise to revolutionize our understanding of Cut20 dynamics:

  • Super-resolution microscopy: Techniques like STORM, PALM, and SIM can visualize APC/C distribution and dynamics at nanoscale resolution in live cells, revealing:

    • Subcellular localization changes during cell cycle progression

    • Co-localization with substrates and regulators

    • Assembly/disassembly dynamics

  • Optogenetics for APC/C control: Developing light-responsive Cut20 variants would allow:

    • Temporal control of APC/C activation with sub-minute precision

    • Spatial restriction of APC/C activity to specific cellular compartments

    • Dose-dependent modulation of activity levels

  • Live-cell biosensors: Engineered FRET-based or split-fluorescent protein sensors can monitor:

    • Cut20 conformational changes

    • APC/C assembly states

    • Substrate ubiquitination in real-time

  • Single-molecule tracking: Techniques for following individual molecules in live cells can reveal:

    • Diffusion dynamics of Cut20-containing complexes

    • Binding/unbinding kinetics with partners

    • Heterogeneity in APC/C populations

  • Genome editing advances: CRISPR-based approaches enable:

    • Endogenous tagging with minimal disruption

    • Rapid generation of allelic series

    • Base editing for precise mutation introduction

These technologies, particularly when combined, will provide unprecedented insights into the dynamic behavior of Cut20 within the living cellular context, complementing the static structural information provided by techniques like cryo-EM that have revealed the APC/C's triangular structure and internal cavity .

How might targeted degradation of Cut20 be exploited for potential therapeutic applications?

While direct therapeutic applications of Cut20 degradation remain exploratory, several promising research directions include:

  • PROTAC development: Design proteolysis-targeting chimeras (PROTACs) specifically targeting Cut20/Apc4 in human cells to:

    • Induce mitotic arrest in cancer cells

    • Sensitize cells to existing anti-mitotic drugs

    • Provide temporal control over APC/C inactivation

  • Selective vulnerability exploration: Identify cancer types with specific dependencies on APC/C function by:

    • Analyzing cancer genomics databases for APC4 alterations

    • Conducting synthetic lethality screens in cancer cell lines

    • Testing Cut20/Apc4 degradation in patient-derived xenografts

  • Cell cycle synchronization applications: Develop reversible Cut20 degradation systems for:

    • Research applications requiring precise cell cycle control

    • Improving synchronization protocols for difficult-to-synchronize cell types

    • Enhancing cellular reprogramming efficiency

  • Comparative studies across species: Leverage S. pombe as a model to understand fundamental aspects of APC/C regulation that might inform human therapeutic strategies.

Methodological approaches would include:

  • Structure-based design of degraders targeting specific Cut20/Apc4 domains

  • Phenotypic screening to identify cell types particularly sensitive to Cut20/Apc4 degradation

  • Time-resolved proteomics to characterize the consequences of acute Cut20/Apc4 loss

These approaches build on our understanding of Cut20's central role in cell cycle regulation, while acknowledging the significant translation challenges from yeast to human systems.

What computational approaches can best predict the functional impact of Cut20 mutations identified in genetic screens?

Advanced computational approaches for predicting Cut20 mutation impacts include:

Practical implementation would involve:

  • Creating a mutation effect prediction pipeline combining multiple approaches

  • Validating predictions with targeted experimental testing

  • Iteratively refining models based on experimental feedback

These computational approaches would complement experimental genetic screens that have already identified important Cut20 mutants like cut20-100 , potentially accelerating the discovery of separation-of-function mutations that could illuminate specific aspects of Cut20 activity.

How do different model organisms compare for studying Cut20/Apc4 function and regulation?

A comparative analysis of model systems reveals distinct advantages for Cut20/Apc4 research:

Model SystemAdvantagesLimitationsKey Methodologies
S. pombePowerful genetics; Temperature-sensitive mutants; Conserved cell cycle; Facile microscopyLess developed proteomics tools; Fewer antibodies availableClassical genetics; Cell cycle synchronization; Live-cell imaging
S. cerevisiaeExtensive genetic tools; Well-developed biochemistry; Easy manipulationLess conserved APC/C regulation compared to humansHigh-throughput screens; Reconstituted systems; Synthetic genetic arrays
Xenopus extractsBiochemically tractable; Cell cycle manipulation; Large scale prepLimited genetics; Not a genetically tractable systemIn vitro cell cycle reconstitution; Depletion-add back experiments
Human cell linesDirect disease relevance; Advanced genomic tools; Comprehensive antibody availabilityMore complex regulation; Slower generation time; Genetic redundancyCRISPR genome editing; Proteomics; High-content imaging

The choice of model system should be guided by the specific research question. For fundamental mechanistic studies of Cut20/Apc4, S. pombe offers significant advantages due to its tractable genetics and the availability of temperature-sensitive mutants like cut20-100 . For translational studies, human cell models become essential despite their greater complexity.

To maximize insights, researchers should consider multi-organism approaches where discoveries in S. pombe can guide more targeted studies in human systems, creating an efficient research pipeline.

What are the relative merits of in vivo versus in vitro approaches for dissecting Cut20 function in the APC/C?

Both in vivo and in vitro approaches offer complementary insights into Cut20 function:

In Vivo Approaches:

  • Strengths: Physiological context; Complete regulatory networks; Authentic post-translational modifications; Real-time dynamics

  • Limitations: Complex interpretations; Indirect effects; Limited manipulation; Technical challenges

  • Key Methods: Temperature-sensitive mutants ; Live-cell imaging; Genetic suppressor screens; Endogenous tagging

In Vitro Approaches:

  • Strengths: Defined components; Direct causality; Quantitative measurements; Systematic manipulation

  • Limitations: Artificial conditions; Missing components; Potential artifacts; Technical complexity

  • Key Methods: Reconstituted ubiquitination assays; Structural studies (cryo-EM ); Binding assays; Post-translational modification mapping

Optimal Integration Strategy:

  • Use in vivo studies to identify phenomena and generate hypotheses

  • Develop in vitro systems to test mechanistic models

  • Return to in vivo systems to validate findings in physiological context

  • Iterate between approaches to refine understanding

How do different ubiquitination assay formats compare for analyzing Cut20's contribution to APC/C activity?

Different ubiquitination assay formats offer distinct advantages for analyzing Cut20's contributions to APC/C function:

Assay FormatKey FeaturesAdvantagesLimitationsBest Applications
Cell extract-basedUses native APC/C from cellsPhysiological conditions; Contains all cofactorsBackground activities; Limited manipulationInitial activity screening; Comparing mutants
Purified componentReconstitutes system from purified proteinsDefined components; Direct causality; QuantitativeTechnical challenges; May miss cofactorsMechanistic studies; Structure-function analysis
Single-moleculeVisualizes individual ubiquitination eventsReveals heterogeneity; Captures dynamicsLow throughput; Technical complexityDetailed kinetic studies; Processivity analysis
FRET-basedReal-time monitoring in solutionContinuous measurements; Potentially in vivo compatibleRequires protein engineering; Indirect readoutKinetic studies; Inhibitor screening
Mass spectrometryIdentifies ubiquitination sitesComprehensive; Quantitative; Site-specificSample preparation complexity; ExpensivePTM mapping; Chain topology analysis

Methodological considerations:

  • Extract preparation: For cell extract assays, the method of extract preparation significantly impacts APC/C activity. High-speed supernatants provide cleaner preparations but may lose important cofactors.

  • Substrate selection: Different APC/C substrates (securin/Cut2, cyclin B/Cdc13) may reveal distinct aspects of Cut20 function. Using multiple substrates provides a more comprehensive view.

  • E2 enzyme choice: The choice of E2 ubiquitin-conjugating enzyme influences chain topology and elongation rates. Testing multiple E2s (UbcH10/Ubc4 and UbcH5 family) provides broader functional insights.

  • Quantification approaches: For robust comparisons between wild-type and mutant Cut20, quantitative readouts using fluorescent substrates or quantitative western blotting are preferred over traditional autoradiography.

The optimal approach depends on the specific research question, with extract-based assays providing physiological relevance and purified systems offering mechanistic precision.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.